Drugs / ALY688-SR
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04855565 Comparator | May → Aug 2021 | — | Allysta Pharmaceutical | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALY688-SR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04855565 ↗ |
| Route | Subcutaneous | “single dose subcutaneous injection” NCT04855565 ↗ |